Skip to main content
. 2022 Jun 30;41(10):1376–1381. doi: 10.1016/j.healun.2022.06.018

Figure 1.

Figure 1

Protocol for Donors Testing Positive for COVID-19: LRT, lower respiratory tract, NPS, nasopharyngeal swab. Hypercoagulability and hyperinflammatory syndrome as previously defined.8 For lung transplants, a period of <20 days was selected based on isolation guidance for immunosuppressed patients from the Centers for Disease Control and Prevention.9 A lower respiratory tract specimen consisted of either a bronchoalveolar lavage specimen or a tracheal aspirate.